ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $793,000 | -51.6% | 23,056 | -59.4% | 0.02% | -45.0% |
| Q4 2016 | $1,639,000 | +173.2% | 56,829 | +201.1% | 0.04% | +185.7% |
| Q3 2016 | $600,000 | -41.5% | 18,872 | -40.2% | 0.01% | -33.3% |
| Q2 2016 | $1,025,000 | +105.4% | 31,576 | +125.6% | 0.02% | +162.5% |
| Q4 2015 | $499,000 | +89.7% | 13,995 | +75.9% | 0.01% | +100.0% |
| Q3 2015 | $263,000 | -57.2% | 7,956 | -45.7% | 0.00% | -63.6% |
| Q2 2015 | $614,000 | +137.1% | 14,659 | +79.6% | 0.01% | +175.0% |
| Q4 2014 | $259,000 | -77.0% | 8,160 | -82.1% | 0.00% | -81.8% |
| Q3 2014 | $1,127,000 | +145.0% | 45,537 | +123.5% | 0.02% | +214.3% |
| Q2 2014 | $460,000 | +46.5% | 20,379 | +61.9% | 0.01% | +133.3% |
| Q4 2013 | $314,000 | +2.6% | 12,589 | +12.8% | 0.00% | -25.0% |
| Q3 2013 | $306,000 | – | 11,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |